These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 21816021)

  • 1. A comparative study of renal dysfunction in patients with inflammatory arthropathies: strong association with cardiovascular diseases and not with anti-rheumatic therapies, inflammatory markers or duration of arthritis.
    Haroon M; Adeeb F; Devlin J; O Gradaigh D; Walker F
    Int J Rheum Dis; 2011 Aug; 14(3):255-60. PubMed ID: 21816021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystatin C is a sensitive marker for detecting a reduced glomerular filtration rate when assessing chronic kidney disease in patients with rheumatoid arthritis and secondary amyloidosis.
    Sato H; Kuroda T; Tanabe N; Ajiro J; Wada Y; Murakami S; Sakatsume M; Nakano M; Gejyo F
    Scand J Rheumatol; 2010; 39(1):33-7. PubMed ID: 20132068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider.
    Neri L; Rocca Rey LA; Lentine KL; Hinyard LJ; Pinsky B; Xiao H; Dukes J; Schnitzler MA
    Am J Kidney Dis; 2011 Sep; 58(3):398-408. PubMed ID: 21783292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystatin C concentration is correlated with disease activity in rheumatoid arthritis patients.
    Targońska-Stepniak B; Majdan M
    Scand J Rheumatol; 2011; 40(5):341-6. PubMed ID: 21619490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Swedish early psoriatic arthritis register-- 2-year followup: a comparison with early rheumatoid arthritis.
    Lindqvist UR; Alenius GM; Husmark T; Theander E; Holmström G; Larsson PT;
    J Rheumatol; 2008 Apr; 35(4):668-73. PubMed ID: 18278834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk factors and not disease activity, severity or therapy associate with renal dysfunction in patients with rheumatoid arthritis.
    Daoussis D; Panoulas VF; Antonopoulos I; John H; Toms TE; Wong P; Nightingale P; Douglas KM; Kitas GD
    Ann Rheum Dis; 2010 Mar; 69(3):517-21. PubMed ID: 19279016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.
    Chitalia N; Raja RB; Bhandara T; Agrawal P; Kaski JC; Jha V; Banerjee D
    J Nephrol; 2010; 23(1):77-84. PubMed ID: 20091490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Risk of Chronic Kidney Disease in Rheumatoid Arthritis Associated with Cardiovascular Complications - A National Population-Based Cohort Study.
    Chiu HY; Huang HL; Li CH; Chen HA; Yeh CL; Chiu SH; Lin WC; Cheng YP; Tsai TF; Ho SY
    PLoS One; 2015; 10(9):e0136508. PubMed ID: 26406879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of glomerular filtration rate: does haemoglobin discriminate between ageing and true CKD?
    Ferrari P; Xiao J; Ukich A; Irish A
    Nephrol Dial Transplant; 2009 Jun; 24(6):1828-33. PubMed ID: 19131346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan.
    Hwang SJ; Lin MY; Chen HC; Hwang SC; Yang WC; Hsu CC; Chiu HC; Mau LW
    Nephrol Dial Transplant; 2008 Oct; 23(10):3192-8. PubMed ID: 18450830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of plasma pentraxin 3 and monocyte chemoattractant protein-1 concentrations with cardiovascular disease in patients with chronic kidney disease.
    Nishi K; Imamura T; Kitamura K; Ogawa T; Fujimoto S; Kakitsubata Y; Ishikawa T; Asada Y; Kodama T
    Ren Fail; 2011; 33(4):398-404. PubMed ID: 21529268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of psoriatic arthritis and rheumatoid arthritis with disease modifying drugs -- comparison of drugs and adverse reactions.
    Helliwell PS; Taylor WJ;
    J Rheumatol; 2008 Mar; 35(3):472-6. PubMed ID: 18203324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M; Kawar B; El Nahas AM
    Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble TWEAK and cardiovascular morbidity and mortality in chronic kidney disease patients.
    Hassan SB; El-demery AB; Ahmed AI; Abukhalil RE
    Arab J Nephrol Transplant; 2012 Jan; 5(1):27-32. PubMed ID: 22283863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum surfactant protein D is associated with the prognosis in patients with chronic kidney disease.
    Xie F; Wang X; Ding Z; Fan P; Fan L; Chen Z; Ma G
    J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):461-5. PubMed ID: 23314596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular death in rheumatoid arthritis: a population-based study.
    Maradit-Kremers H; Nicola PJ; Crowson CS; Ballman KV; Gabriel SE
    Arthritis Rheum; 2005 Mar; 52(3):722-32. PubMed ID: 15751097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.
    Rioja I; Hughes FJ; Sharp CH; Warnock LC; Montgomery DS; Akil M; Wilson AG; Binks MH; Dickson MC
    Arthritis Rheum; 2008 Aug; 58(8):2257-67. PubMed ID: 18668547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma adiponectin levels in chronic kidney disease patients: relation with molecular inflammatory profile and metabolic status.
    Norata GD; Baragetti I; Raselli S; Stucchi A; Garlaschelli K; Vettoretti S; Piloni G; Buccianti G; Catapano AL
    Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):56-63. PubMed ID: 19359150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.